Through a recent award obtained by Baylor College of Medicine, the Sabin Vaccine Institute Product Development Partnership (Sabin PDP) will collaborate as part of a consortiom with key partners at the New York Blood CenterUniversity of Texas Medical BranchImmune Design Corporation and Walter Reed Army Institute of Research, in the development of a new vaccine to prevent severe acute respiratory syndrome (SARS). The product development processes for the prototype vaccine are being developed at the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development. The vaccine is expected to be ready for clinical testing by 2017.